You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
7 January 2020
Velabs Therapeutics GmbH: Velabs Therapeutics receives exclusive licence from alytas therapeutics for the development of therapeutic antibodies as senolytics